Antitrust Blog
The Antitrust Blog features observations and analysis relating to developments in the world of federal and state competition-law enforcement, including updates on enforcement actions, agency policy statements and recent court decisions.
Latest Posts
Less Is More? Implications of the DOJ's $650 million Action Against KKR & Co.
Antitrust Under Trump 2.0: No More "Hipster Antitrust," But Scrutiny Will Remain
FTC Bags Preliminary Injunction in Challenge to "Affordable Luxury" Handbag Merger
DOJ Introduces New Twist in Algorithmic Collusion Cases
The Latest on RealPage Collusion-by-Algorithm Litigation
Latest Collusion-by-Algorithm Ruling Offers More of Same, but a Significant New Twist
Gibson Decision Hands Atlantic City Casino-Hotels Dismissal of Price-Fixing Claims
The Increasing Scrutiny of Healthcare Transactions
Understanding Chamber of Commerce v. FTC and Its Implications for the HSR Act
DOJ, States Move to Prevent Merger of Home Health Giants UnitedHealth Group and Amedisys
Federal Court Searches for Answers in Antitrust Ad Tech Trial Against Google
Orange Book Concerns Pick Up as Yet Another Issue for Pharmaceutical Manufacturers
This Blog/Website ("Blog") does not provide specific legal advice. It is for educational purposes only. Use of the Blog does not create any attorney-client relationship between you and Holland & Knight LLP or the author(s) of any posts. The Blog does not constitute legal advice and is not a substitute for competent legal advice from a licensed attorney in your state. Any links from another site to the Blog are beyond the control of Holland & Knight LLP and do not convey their approval, support or any relationship to any site or organization.
Subscribe to Antitrust Alerts Sign Up
Meet Our Editors
Learn More About Our Antitrust Practices
